ResMed set to raise up to $172.5 million
This article was originally published in Clinica
ResMed, which makes and sells equipment for the diagnosis and treatment of sleep-disordered breathing, plans to raise $150 million through a private placement of its convertible subordinated notes, due 2006. The New York company says it may increase its sale by $22.5 million if there is sufficient demand. It plans to use part of the proceeds to pay down debt taken on to buy MAP Medizin-Technologie in February.